Outset Medical Inc reports results for the quarter ended June 30 - Earnings Summary

• Outset Medical Inc OM.OQ reported a quarterly adjusted loss of 84 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-7.05. The mean expectation of five analysts for the quarter was for a loss of 98 cents per share. Wall Street expected results to range from $-1.76 to -64 cents per share.

• Revenue rose 14.7% to $31.42 million from a year ago; analysts expected $29.41 million.

• Outset Medical Inc's reported EPS for the quarter was a loss of $1.04​.

• The company reported a quarterly loss of $18.54 million.

• Outset Medical Inc shares had fallen by 26.6% this quarter and lost 15.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Outset Medical Inc is $23.00, about 38.7% above its last closing price of $14.10

This summary was machine generated from LSEG data August 6 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)